Genscript Biotech Corporation (HKG:1548)
16.05
-0.18 (-1.11%)
Oct 28, 2025, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 35.07 billion as of October 29, 2025. Its market cap has increased by 13.47% in one year.
Market Cap
35.07B
Enterprise Value
32.06B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.44
Stock Price
16.05
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 35.07B, an increase of 1,560.72%. That is a compound annual growth rate of 33.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 35.07B | 66.26% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | 22.03B | -33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 201.53B |
| WuXi Biologics | 151.53B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 126.75B |
| Akeso | 106.48B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.18B |